Amedeo Smart

Free Medical Literature Service

 

Amedeo

Ischemic Heart Disease
  Free Subscription

Articles published in
Ann Intern Med
    September 2026
  1. ARNOLD MJ, Spacek L, Bush KNV, Waring AA, et al
    A Synopsis of the 2025 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline for Lipid Management for Cardiovascular Disease Risk Reduction.
    Ann Intern Med. 2026 Sep 15. doi: 10.7326/ANNALS-26-01374.
    >> Share

  2. ALSAARAN Z, Hill MD
    In AIS with inadequate response to tenecteplase, tirofiban vs. placebo increased excellent functional outcome rate at 90 d.
    Ann Intern Med. 2026 Sep 1. doi: 10.7326/ANNALS-26-03132.
    >> Share

  3. WEITZ HH, Merli GJ
    Annals Consult Guys - Chronic Cardiovascular Disease: Aligning Prevention With Newer Recommendations.
    Ann Intern Med. 2026;179:e2603768CG.
    >> Share

    August 2026
  4. CAI A, Bayes-Genis A, Wolfe R, Tonkin AM, et al
    Longitudinal Changes in Heart Stress and the Risk for Cardiovascular Disease and Mortality in Older Adults : An Observational Study.
    Ann Intern Med. 2026 Aug 18. doi: 10.7326/ANNALS-26-00245.
    >> Share

  5. HUFF C
    New mothers' cardiovascular health considered.
    Ann Intern Med. 2026 Aug 18. doi: 10.7326/ANNALS-26-03450.
    >> Share

  6. LIBMAN H, O'Glasser AY, Fleischmann KE, Kanjee Z, et al
    How Would You Manage Perioperative Cardiovascular Risk for Noncardiac Surgery in This Patient With Complex Comorbidity? Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
    Ann Intern Med. 2026 Aug 11. doi: 10.7326/ANNALS-26-02584.
    >> Share

  7. YANG Y, Shen CY, Cheng MC, Kang W, et al
    Real-World Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Mitral Stenosis : A Target Trial Emulation.
    Ann Intern Med. 2026 Aug 11. doi: 10.7326/ANNALS-25-04740.
    >> Share

  8. MATHEW A
    Blood pressure-lowering drugs reduce risk for major cardiovascular events regardless of CKD G category.
    Ann Intern Med. 2026 Aug 4. doi: 10.7326/ANNALS-26-02816.
    >> Share

    June 2026
  9. FIELD TS
    In basilar artery occlusion, tenecteplase within 24 h of symptom onset improved functional outcome vs. usual care at 90 d.
    Ann Intern Med. 2026 Jun 2. doi: 10.7326/ANNALS-26-01704.
    >> Share

  10. KESARWANI M
    P2Y12 inhibitor monotherapy vs. DAPT soon after PCI for ACS increased a composite of death or ischemic events at 30 d but not at 1 y.
    Ann Intern Med. 2026;179:JC66.
    >> Share

    May 2026
  11. LO B
    Tenecteplase 4.5 to 24 h after non-LVO stroke with potentially salvageable brain tissue improved functional outcomes at 90 d.
    Ann Intern Med. 2026 May 5. doi: 10.7326/ANNALS-26-01142.
    >> Share

  12. ATALLA M, Gupta V, Khalid M, Kussmaul WG, et al
    Cardiology: What You May Have Missed in 2025.
    Ann Intern Med. 2026;179.
    >> Share

    March 2026
  13. DONATO A
    In adults at high CV risk and without previous MI or stroke, evolocumab reduced major adverse CV event composites at a median 4.6 y.
    Ann Intern Med. 2026 Mar 3. doi: 10.7326/ANNALS-25-05604.
    >> Share

    February 2026

  14. Correction: Chronic Coronary Artery Disease.
    Ann Intern Med. 2026 Feb 10. doi: 10.7326/ANNALS-26-00353.
    >> Share

  15. MUKHERJEE D
    In AF with drug-eluting stent for >/=1 y, NOACs were noninferior to NOAC + clopidogrel for a composite of adverse clinical events at 1 y.
    Ann Intern Med. 2026 Feb 3. doi: 10.7326/ANNALS-25-05478.
    >> Share

  16. KELSEY MD
    In patients with CAD, clopidogrel vs. aspirin monotherapy reduces MACCE without increasing major bleeding.
    Ann Intern Med. 2026;179:JC16.
    >> Share

    January 2026
  17. RAMASWAMY R
    In older adults with impaired physical performance after MI, multidomain rehabilitation reduced CV death or CV hospitalization at 1 y.
    Ann Intern Med. 2026;179:JC5.
    >> Share

    December 2025
  18. YAN VKC, Blais JE, Gamble JM, Chan EWY, et al
    Effectiveness and Safety of Statins in Type 2 Diabetes According to Baseline Cardiovascular Risk : A Target Trial Emulation Study.
    Ann Intern Med. 2025 Dec 30. doi: 10.7326/ANNALS-25-00662.
    >> Share

  19. STEEN JP, Klatt KC, Chang Y, Guyatt GH, et al
    Effect of Interventions Aimed at Reducing or Modifying Saturated Fat Intake on Cholesterol, Mortality, and Major Cardiovascular Events : A Risk Stratified Systematic Review of Randomized Trials.
    Ann Intern Med. 2025 Dec 16. doi: 10.7326/ANNALS-25-02229.
    >> Share

  20. ESTRUCH R, Lamuela-Raventos RM
    Saturated Fats and Cardiovascular Disease: From Avoidance to a Nuanced Recommendation.
    Ann Intern Med. 2025 Dec 16. doi: 10.7326/ANNALS-25-04971.
    >> Share


  21. Annals Video Summary - Effect of Interventions Aimed at Reducing or Modifying Saturated Fat Intake on Cholesterol, Mortality, and Major Cardiovascular Events.
    Ann Intern Med. 2025 Dec 16:e2504737VS. doi: 10.7326/ANNALS-25-04737.
    >> Share


  22. Correction: Chronic Coronary Artery Disease.
    Ann Intern Med. 2025 Dec 9. doi: 10.7326/ANNALS-25-05126.
    >> Share

  23. MEI DA, Romiti GF
    In patients with chronic coronary syndrome and high atherothrombotic risk, adding aspirin to OAC increased adverse CV events at 2 y.
    Ann Intern Med. 2025 Dec 2. doi: 10.7326/ANNALS-25-04685.
    >> Share

  24. LEIVA O, Elgendy IY
    In adults with MI and LVEF >40% after invasive care, beta-blocker therapy did not reduce a composite adverse outcome at a median 3.7 y.
    Ann Intern Med. 2025;178:JC134.
    >> Share

  25. LEIVA O, Elgendy IY
    In adults with MI and LVEF >/=40%, beta-blocker therapy reduced a composite adverse outcome at a median 3.5 y.
    Ann Intern Med. 2025;178:JC135.
    >> Share

  26. BATES ER
    P2Y12 inhibitor monotherapy soon after PCI for ACS was not noninferior to DAPT for a composite of death or ischemic events.
    Ann Intern Med. 2025;178:JC137.
    >> Share

  27. BATES ER
    After successful PCI for AMI and 1 mo of DAPT, P2Y12 inhibitor monotherapy was noninferior to continued DAPT for adverse outcomes.
    Ann Intern Med. 2025;178:JC136.
    >> Share

  28. LIM LS
    In healthy older adults, low-dose aspirin for a median 4.7 y did not reduce MACE but increased major hemorrhage at a median 8.3 y.
    Ann Intern Med. 2025;178:JC139.
    >> Share

    November 2025

  29. Correction: Step Accumulation Patterns and Risk for Cardiovascular Events and Mortality Among Suboptimally Active Adults.
    Ann Intern Med. 2025 Nov 25. doi: 10.7326/ANNALS-25-04990.
    >> Share

  30. HEERSPINK HJL, Grams ME, Sang Y, Ballew SH, et al
    Proteinuria or Albuminuria as Markers of Kidney and Cardiovascular Disease Risk : An Individual Patient-Level Meta-analysis.
    Ann Intern Med. 2025 Nov 4. doi: 10.7326/ANNALS-25-02117.
    >> Share

    October 2025
  31. DEL POZO CRUZ B, Ahmadi M, Sabag A, Saint Maurice PF, et al
    Step Accumulation Patterns and Risk for Cardiovascular Events and Mortality Among Suboptimally Active Adults.
    Ann Intern Med. 2025 Oct 28. doi: 10.7326/ANNALS-25-01547.
    >> Share

  32. KITTLESON MM
    Chronic Coronary Artery Disease.
    Ann Intern Med. 2025 Oct 14. doi: 10.7326/ANNALS-25-03512.
    >> Share

    September 2025
  33. FIELD TS
    In AIS due to LVO presenting within 4.5 h of onset, adding tenecteplase to EVT increased functional independence at 90 d.
    Ann Intern Med. 2025 Sep 2. doi: 10.7326/ANNALS-25-03337.
    >> Share

    August 2025
  34. PAGANO MB, Stanworth SJ, Dennis J, Bakhtary S, et al
    Red Cell Transfusion in Acute Myocardial Infarction: AABB International Clinical Practice Guidelines.
    Ann Intern Med. 2025 Aug 19. doi: 10.7326/ANNALS-25-00706.
    >> Share

  35. OGUNTALA JO, Yan AT
    Toward Evidence-Based Transfusion for Anemia in Acute Myocardial Infarction: Still an Unfinished Story.
    Ann Intern Med. 2025 Aug 19. doi: 10.7326/ANNALS-25-02486.
    >> Share

  36. CENTOR RM, Kip K, Saeed A
    Web Exclusive. Annals On Call - Semaglutide Versus Dulaglutide or Empagliflozin: Death and Cardiovascular Outcomes for Patients With Type 2 Diabetes.
    Ann Intern Med. 2025;178:e2503594OC.
    >> Share

    July 2025
  37. AGGARWAL R, Wadhera RK, Chiu N, Szarek M, et al
    Cardiovascular Risk Factor and Disease Mortality Among Asian Indian, Chinese, and Filipino Adults in the United States, 2018 to 2023.
    Ann Intern Med. 2025 Jul 29. doi: 10.7326/ANNALS-25-00108.
    >> Share

  38. SHAHID M, Gandhi GY
    In patients with diabetes and previous MI, high-dose multivitamins and minerals did not reduce CV events.
    Ann Intern Med. 2025 Jul 1. doi: 10.7326/ANNALS-25-02174.
    >> Share

    June 2025
  39. SAEED A, Mulukutla SR, Thoma F, Lemon L, et al
    Comparison of Semaglutide or Dulaglutide Versus Empagliflozin for Risk for Death and Cardiovascular Outcomes Among Patients With Type 2 Diabetes : Two Target Trial Emulation Studies.
    Ann Intern Med. 2025 Jun 17. doi: 10.7326/ANNALS-24-00775.
    >> Share


  40. Summary for Patients: Semaglutide or Dulaglutide Versus Empagliflozin for Risk for Death and Cardiovascular Outcomes Among Patients With Type 2 Diabetes.
    Ann Intern Med. 2025 Jun 17. doi: 10.7326/ANNALS-24-00775.
    >> Share

  41. BATUR P
    Some combined and progestin-only contraceptives were linked to increased risk for ischemic stroke and myocardial infarction.
    Ann Intern Med. 2025 Jun 3. doi: 10.7326/ANNALS-25-01774.
    >> Share

  42. OGUNTALA JO, Yan AT
    In AF with stable CAD, an OAC alone does not increase ischemic events and reduces major bleeding vs. OAC + SAPT at a mean 22 mo.
    Ann Intern Med. 2025;178:JC65.
    >> Share

  43. DUNN AS
    In ACS with DES, de-escalating DAPT to ticagrelor alone vs. standard DAPT reduces major bleeding without increasing ischemic events.
    Ann Intern Med. 2025;178:JC66.
    >> Share

  44. AU YEUNG SL, Luo S, Schooling CM
    Associations of Testosterone and Related Hormones With All-Cause and Cardiovascular Mortality and Incident Cardiovascular Disease in Men.
    Ann Intern Med. 2025;178:905.
    >> Share

  45. SELINGER S
    Associations of Testosterone and Related Hormones With All-Cause and Cardiovascular Mortality and Incident Cardiovascular Disease in Men.
    Ann Intern Med. 2025;178:904-905.
    >> Share

  46. LIN YH, Lin KJ, Chen JY, Juang HH, et al
    Associations of Testosterone and Related Hormones With All-Cause and Cardiovascular Mortality and Incident Cardiovascular Disease in Men.
    Ann Intern Med. 2025;178:905-906.
    >> Share

  47. YEAP BB, Wittert GA, Wu FCW, Vanderschueren D, et al
    Associations of Testosterone and Related Hormones With All-Cause and Cardiovascular Mortality and Incident Cardiovascular Disease in Men.
    Ann Intern Med. 2025;178:906-907.
    >> Share

    May 2025
  48. MANSOOR H, Elgendy IY
    In AF with recent ACS or PCI, apixaban reduced total bleeding vs. VKA; aspirin increased total bleeding vs. placebo at 6 mo.
    Ann Intern Med. 2025;178:JC57.
    >> Share

  49. KHATTAK S, Al-Ansari A, Alfaraidhy M, Rajah F, et al
    Cardiology: What You May Have Missed in 2024.
    Ann Intern Med. 2025;178.
    >> Share

    April 2025
  50. CIACCI P, Romiti GF, Corica B
    In older adults with severe AS and complex CAD, PCI + TAVI vs. SAVR + CABG reduced patient-oriented outcomes at 1 y.
    Ann Intern Med. 2025;178:JC45.
    >> Share

    March 2025
  51. NTSEKHE M
    Low Prevalence of Coronary Artery Disease Among Ugandans With and Without HIV: Local Anomaly or Regional Reality?
    Ann Intern Med. 2025 Mar 12. doi: 10.7326/ANNALS-24-03940.
    >> Share

  52. SIEDNER MJ, Ghoshhajra B, Erem G, Nassanga R, et al
    Epidemiology of Coronary Atherosclerosis Among People Living With HIV in Uganda : A Cross-Sectional Study.
    Ann Intern Med. 2025 Mar 12. doi: 10.7326/ANNALS-24-02233.
    >> Share

  53. LADER EW
    In previous MI with ventricular tachycardia (VT), catheter ablation reduced mortality or VT events more than antiarrhythmic drug therapy at 4 y.
    Ann Intern Med. 2025 Mar 4. doi: 10.7326/ANNALS-25-00336.
    >> Share

  54. OGUNTALA JO, Yan AT
    In acute MI and acute or chronic anemia, liberal vs. restrictive transfusion did not affect recurrent MI or death.
    Ann Intern Med. 2025 Mar 4. doi: 10.7326/ANNALS-25-00161.
    >> Share

  55. KELSEY MD, Newby LK
    In patients with acute MI, spironolactone did not reduce cardiac events at 3 y.
    Ann Intern Med. 2025;178:JC33.
    >> Share

  56. KELSEY MD, Newby LK
    In patients with acute MI, colchicine did not reduce cardiac events at 3 y.
    Ann Intern Med. 2025;178:JC32.
    >> Share

    February 2025
  57. LEE YJ, Gao X, Lee SH, Kan J, et al
    De-escalating Dual Antiplatelet Therapy to Ticagrelor Monotherapy in Acute Coronary Syndrome : A Systemic Review and Individual Patient Data Meta-Analysis of Randomized Clinical Trials.
    Ann Intern Med. 2025 Feb 18. doi: 10.7326/ANNALS-24-03102.
    >> Share


  58. Annals Video Summary - De-escalating Dual Antiplatelet Therapy to Ticagrelor Monotherapy in Acute Coronary Syndrome.
    Ann Intern Med. 2025 Feb 18:e2500013VS. doi: 10.7326/ANNALS-25-00013.
    >> Share

  59. WEITZ HH, Merli GJ
    Web Exclusive. Annals Consult Guys - Care of Patients With Low Cardiac Risk but Incidental Coronary Artery Calcification.
    Ann Intern Med. 2025;178:e2500667CG.
    >> Share

    January 2025
  60. MASUDA S, Fukasawa T, Matsuda S, Kawakami K, et al
    Cardiovascular Safety and Fracture Prevention Effectiveness of Denosumab Versus Oral Bisphosphonates in Patients Receiving Dialysis : A Target Trial Emulation.
    Ann Intern Med. 2025 Jan 7. doi: 10.7326/ANNALS-24-03237.
    >> Share

  61. MORENO R
    In asymptomatic severe AS, early surgery vs. conservative therapy reduced a composite of death, MI, stroke, or HF hospitalization at 63 mo.
    Ann Intern Med. 2025 Jan 7. doi: 10.7326/ANNALS-24-03367.
    >> Share

  62. RICH MW
    In adults aged >/=75 y with NSTEMI, an invasive vs. conservative strategy did not improve a composite outcome at a median 4.1 y.
    Ann Intern Med. 2025;178:JC5.
    >> Share

    December 2024

  63. Correction: Deep Learning to Estimate Cardiovascular Risk From Chest Radiographs.
    Ann Intern Med. 2024 Dec 17. doi: 10.7326/ANNALS-24-03386.
    >> Share

  64. NADERIAN M, Norland K, Schaid DJ, Kullo IJ, et al
    Development and Evaluation of a Comprehensive Prediction Model for Incident Coronary Heart Disease Using Genetic, Social, and Lifestyle-Psychological Factors: A Prospective Analysis of the UK Biobank.
    Ann Intern Med. 2024 Dec 10. doi: 10.7326/ANNALS-24-00716.
    >> Share

  65. CENTOR RM, Carson JL, Brooks MM
    Web Exclusive. Annals On Call - Transfusion Thresholds in Myocardial Infarction.
    Ann Intern Med. 2024;177:e2403587OC.
    >> Share

  66. WEITZ HH, Merli GJ
    Web Exclusive. Annals Consult Guys - Cholesterol Management in Older Patients After Myocardial Infarction.
    Ann Intern Med. 2024;177:e2403798CG.
    >> Share

  67. LADER E
    In stable CAD and aortic stenosis, adding routine PCI to TAVI reduced MACE but increased bleeding at 2 y.
    Ann Intern Med. 2024;177:JC139.
    >> Share

  68. KESARWANI M
    After PCI for ACS or stable CAD, DAPT for 1 mo vs. >1 mo reduces major bleeding without increasing stent thrombosis.
    Ann Intern Med. 2024;177:JC138.
    >> Share

    November 2024
  69. GIBSON LE, Wiener-Kronish JP, Fleisher LA
    From Risk to Recovery: Looking Ahead to the Next 50 Years of Preoperative Cardiovascular Assessment.
    Ann Intern Med. 2024 Nov 12. doi: 10.7326/ANNALS-24-02405.
    >> Share

    October 2024
  70. WOODRUFF RC, Kaholokula JK, Riley L, Tong X, et al
    Cardiovascular Disease Mortality Among Native Hawaiian and Pacific Islander Adults Aged 35 Years or Older, 2018 to 2022.
    Ann Intern Med. 2024 Oct 15. doi: 10.7326/M24-0801.
    >> Share

  71. FITCH KV, Zanni MV, Manne-Goehler J, Diggs MR, et al
    Diabetes Risk Factors in People With HIV Receiving Pitavastatin Versus Placebo for Cardiovascular Disease Prevention : A Randomized Trial.
    Ann Intern Med. 2024 Oct 8. doi: 10.7326/ANNALS-24-00944.
    >> Share

  72. PORTELA GT, Carson JL, Swanson SA, Alexander JH, et al
    Effect of Four Hemoglobin Transfusion Threshold Strategies in Patients With Acute Myocardial Infarction and Anemia : A Target Trial Emulation Using MINT Trial Data.
    Ann Intern Med. 2024 Oct 1. doi: 10.7326/M24-0571.
    >> Share

  73. BLOCH EM, Tobian AAR
    Relaxing Transfusion Thresholds for Patients With Myocardial Infarction: Findings From the MINT Trial.
    Ann Intern Med. 2024 Oct 1. doi: 10.7326/M24-0895.
    >> Share

  74. SHARMA M, Srivastva A
    In ischemic stroke treated within 4.5 h, reteplase vs. alteplase increased excellent functional outcome at 90 d.
    Ann Intern Med. 2024 Oct 1. doi: 10.7326/ANNALS-24-02228.
    >> Share

    September 2024
  75. SEE C, Mooghali M, Dhruva SS, Ross JS, et al
    Class I Recalls of Cardiovascular Devices Between 2013 and 2022 : A Cross-Sectional Analysis.
    Ann Intern Med. 2024 Sep 17. doi: 10.7326/ANNALS-24-00724.
    >> Share

  76. MINHAS AMK, Virani SS, Michos ED, Nambi V, et al
    Comparing Cardiovascular Risk Classification of U.S. Adults According to Pooled Cohort Equations and PREVENT Equations: Cross-Sectional Analysis of the National Health and Nutrition Examination Survey.
    Ann Intern Med. 2024 Sep 3. doi: 10.7326/ANNALS-24-00074.
    >> Share

  77. FATH AR, Elgendy IY
    After ACS, telemedicine-based care with remote patient monitoring vs. usual care reduced hospital readmissions at 6 mo.
    Ann Intern Med. 2024;177:JC105.
    >> Share

  78. MUKHERJEE D
    In patients with NSTE-ACS and previous CABG, routine invasive vs. conservative management does not improve outcomes.
    Ann Intern Med. 2024;177:JC104.
    >> Share

    August 2024
  79. CHAITOFF A, Bendicksen L, Feldman WB, Zheutlin AR, et al
    Estimating New Eligibility and Maximum Costs of Expanded Medicare Coverage of Semaglutide for Cardiovascular Risk Prevention.
    Ann Intern Med. 2024 Aug 27. doi: 10.7326/ANNALS-24-00308.
    >> Share

  80. ANDERSON TS, Yeh RW, Herzig SJ, Marcantonio ER, et al
    Trends and Disparities in Ambulatory Follow-Up After Cardiovascular Hospitalizations : A Retrospective Cohort Study.
    Ann Intern Med. 2024 Aug 6. doi: 10.7326/M23-3475.
    >> Share

  81. CLIFFORD C, Yan AT
    After PCI and 1 mo of DAPT for ACS, ticagrelor alone vs. continued DAPT for 11 mo reduced bleeding without increasing MACCE.
    Ann Intern Med. 2024;177:JC86.
    >> Share

  82. SULEIMAN B, Granger CB
    In MI with preserved LVEF, long-term beta-blocker use vs. no use did not reduce all-cause death or MI at 3.5 y.
    Ann Intern Med. 2024;177:JC88.
    >> Share

    July 2024
  83. KEPPEL S, Borzak S
    In adults with AMI who are at risk for HF, empagliflozin did not reduce a composite of first HF hospitalization or all-cause death at 18 mo.
    Ann Intern Med. 2024;177:JC74.
    >> Share

    June 2024
  84. GUPTA M, Gulati S, Nasir K, Sarraju A, et al
    Aspirin Use Prevalence for Cardiovascular Disease Prevention Among U.S. Adults From 2012 to 2021.
    Ann Intern Med. 2024 Jun 25. doi: 10.7326/M24-0427.
    >> Share

  85. GUALLAR E, Bravo PE, Ferrari VA
    Feeling the Heat: Cardiovascular Consequences of Heat Exposure Under Controlled Experimental Conditions.
    Ann Intern Med. 2024 Jun 11. doi: 10.7326/M24-0882.
    >> Share

  86. BARRY H, Iglesies-Grau J, Chaseling GK, Paul J, et al
    The Effect of Heat Exposure on Myocardial Blood Flow and Cardiovascular Function.
    Ann Intern Med. 2024 Jun 11. doi: 10.7326/M24-3504.
    >> Share


  87. Correction: Diagnostic Strategies for the Assessment of Suspected Stable Coronary Artery Disease: A Systematic Review and Meta-analysis.
    Ann Intern Med. 2024 Jun 4. doi: 10.7326/ANNALS-24-00550.
    >> Share

  88. CHIA JE, Mukherjee D
    After stent implantation for ACS, ticagrelor monotherapy after <1 mo of DAPT vs. 12 mo of DAPT improved 1-y net clinical benefit.
    Ann Intern Med. 2024;177:JC64.
    >> Share

    May 2024

  89. Annals Video Summary - Associations of Testosterone and Related Hormones With All-Cause and Cardiovascular Mortality and Incident Cardiovascular Disease in Men.
    Ann Intern Med. 2024 May 14:eM240479. doi: 10.7326/M24-0479.
    >> Share

  90. YEAP BB, Marriott RJ, Dwivedi G, Adams RJ, et al
    Associations of Testosterone and Related Hormones With All-Cause and Cardiovascular Mortality and Incident Cardiovascular Disease in Men : Individual Participant Data Meta-analyses.
    Ann Intern Med. 2024 May 14. doi: 10.7326/M23-2781.
    >> Share

  91. BATES ER
    In patients with type 2 diabetes and recent MI, colchicine reduced a composite CV outcome at 23 mo.
    Ann Intern Med. 2024 May 7. doi: 10.7326/J24-0026.
    >> Share

  92. WEITZ HH, Merli GJ, Carson JL
    Web Exclusive. Annals Consult Guys - Acute Coronary Syndrome and Anemia: When to Transfuse?
    Ann Intern Med. 2024;177:eW240002.
    >> Share

    April 2024
  93. YEN FS, Hwu CM, Liu JS, Wu YL, et al
    Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Dialysis and Cardiovascular Disease in Patients With Stage 5 Chronic Kidney Disease.
    Ann Intern Med. 2024 Apr 30. doi: 10.7326/M23-1874.
    >> Share

  94. GREENWOOD H, Barnes K, Clark J, Ball L, et al
    Long-Term Effect of Salt Substitution for Cardiovascular Outcomes : A Systematic Review and Meta-Analysis.
    Ann Intern Med. 2024 Apr 9. doi: 10.7326/M23-2626.
    >> Share


  95. Annals Video Summary - Long-Term Effect of Salt Substitution for Cardiovascular Outcomes: A Systematic Review and Meta-analysis.
    Ann Intern Med. 2024 Apr 9:eM240208. doi: 10.7326/M24-0208.
    >> Share

  96. KIRSCHNER J, Hunter B
    In suspected ACS, hs-cTnI- vs. c-cTnI-guided care was associated with improved outcomes at 5 y in certain subgroups.
    Ann Intern Med. 2024;177:JC41.
    >> Share

    March 2024
  97. WEISS J, Raghu VK, Paruchuri K, Zinzuwadia A, et al
    Deep Learning to Estimate Cardiovascular Risk From Chest Radiographs : A Risk Prediction Study.
    Ann Intern Med. 2024 Mar 26. doi: 10.7326/M23-1898.
    >> Share

  98. MUKHERJEE D
    In acute MI and anemia, restrictive vs. liberal transfusion did not differ for a composite of recurrent MI or death at 30 d.
    Ann Intern Med. 2024 Mar 5. doi: 10.7326/J24-0010.
    >> Share

  99. BAVISHI C
    In adults with stable angina, PCI vs. a placebo procedure reduced angina symptoms at 12 wk.
    Ann Intern Med. 2024;177:JC28.
    >> Share

  100. YONIS H, Granger CB
    In adults aged >/=80 y with NSTE-ACS, an invasive vs. conservative strategy improved outcomes at a median 5.3 y.
    Ann Intern Med. 2024;177:JC27.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016